References
- Beresford A. P., Macrae P. V., Stopher D. A. Metabolism of amlodipine in the rat and the dog: a species difference. Xenobiotica 1988; 18: 169–182
- Carpi C., Gaviraghi G., Semeraro C. GX 1048 (GR 43659X) a new dihydropyridine calcium antagonist with potent and long lasting antihypertensive action. British Journal of Pharmacology 1986; 89(Proc. Suppl.)758P
- Higuchi S., Sasaki H., Shiobara Y., Sado T. Absorption, excretion and metabolism of a new dihydropyridine diester cerebral vasodilator in rats and dogs. Xenobiotica 1977; 7: 469–479
- Medenwald H., Schlobmann K., Wünsche C. Strukturaufklärung der renalen ausscheidungsprodukte von (4-(2-Nitrophenyl)-2,6-dimethyl-1,4-dihydropyridin-3,5-dicarbonsäuredi methylester. Arzneimittel-Forschung 1972; 22: 53–56
- Meyer H., Wehinger E., Bossert F., Sherling D. Nimodipine: synthesis and metabolic pathway. Arzneimittel-Forschung 1983a; 33: 106–112
- Meyer H., Scherling D., Karl W. Nitrendipine: identification and synthesis of main metabolites. Arzneimittel-Forschung 1983b; 33: 1528–1534
- Micheli D., Collodel A., Semeraro C., Gaviraghi G., Carpi C. Lacidipine: a calcium antagonist with potent and long-lasting antihypertensive effects in animal studies. Journal of Cardiovascular Pharmacology 1990; 15(Suppl. 4)666–675
- Parinov V. J., Odinec A. G., Gilev A. P., Dubur G. J., Muceniece D. H., Ozol J. J., Shatz V. D., Gavars M. P., Vigante B. A. Pharmacokinetics and metabolism of ryodipine in rats. Arzneimittel-Forschung 1985; 35: 808–813
- Pellegatti M., Grossi P., Ayrton J., Evans G. L, Harker A. J. Absorption, distribution and excretion of lacidipine, a dihydropyridine calcium antagonist, in rat and dog. Xenobiotica 1990; 20(8)765–777
- Scheeling D., Karl W., Ahr G., Ahr H. J., Wehinger E. Pharmacokinetics of nisoldipine III. Biotransformation of nisoldipine in rat, dog, monkey and man. Arzneimittel-Forschung 1988; 38: 1105–1110
- Takayama F., Iwasawa Y., Saito K., Shiratori K., Ohtawa M. Metabolism of a new dihydropyridine calcium antagonist in rats and dogs. Xenobiotica 1989; 19: 1407–1420
- Terashita S., Tokuma Y., Fujiwara T., Shiokawa Y., Okumura K., Noguchi H. Metabolism of nilvadipine, a new dihydropyridine calcium antagonist, in rats and dogs. Xenobiotica 1987; 17: 1415–1425
- Walkenstein S. S., Intoccia A. P., Flanagan T. L., Hwang B., Flint D., Weinstock J., Villani A. J., Blackburn D., Green H. Metabolism of the antihypertensive agent 1,4-dihydro-2,6-dimethyl-4-(2-trifluoromethylphenyl)-3,5-pyridine dicarboxylic acid diethylester. Journal of Pharmaceutical Science 1973; 62: 580–584
- Weidolf L., Borg K. O., Hoffmann K.-J. Urinary metabolites of felodipine, a new vasodilating drug, in man, dog, rat and mouse. Xenobiotica 1984; 14: 657–666